Page last updated: 2024-11-03

rimantadine and Opportunistic Infections

rimantadine has been researched along with Opportunistic Infections in 1 studies

Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.

Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.

Research Excerpts

ExcerptRelevanceReference
"The importance and significance of amantadine- or rimantadine-resistant influenza viruses in immunocompromised patients was studied in a population of adult bone marrow transplant (BMT) recipients and patients with leukemia prospectively cultured for respiratory viruses."3.70Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. ( Atmar, RL; Champlin, RE; Cox, NJ; Englund, JA; Kantarjian, H; Klimov, AI; Regnery, H; Tarrand, J; Whimbey, E; Wyde, PR; Yousuf, H, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Englund, JA1
Champlin, RE1
Wyde, PR1
Kantarjian, H1
Atmar, RL1
Tarrand, J1
Yousuf, H1
Regnery, H1
Klimov, AI1
Cox, NJ1
Whimbey, E1

Other Studies

1 other study available for rimantadine and Opportunistic Infections

ArticleYear
Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:6

    Topics: Adult; Amantadine; Antiviral Agents; Bone Marrow Transplantation; Drug Resistance, Microbial; Humans

1998